Iran Goudarzi, Mohammadreza Kaffashian, Mohammad Shabani, Hashem Haghdoost-Yazdi, Gila Behzadi, Mahyar Janahmadi
Index: Eur. J. Pharmacol. 642(1-3) , 56-65, (2010)
Full Text: HTML
Electrophysiological dysfunction of Purkinje cells causes cerebellar ataxia. Recent studies indicated that 4-aminopyridine (4-AP) can prevent the attacks in patients with episodic ataxia type 2. However, the cellular mechanism(s) by which 4-AP might be beneficial for the improvement of motor function remain unclear. Here, electrophysiological and behavioural consequences of in vivo co-treatment with 4-AP against 3-acetylpyridine (3-AP)-induced ataxia in rats were assessed. Combined treatment with 4-AP partially improved motor behaviour compared to the ataxic rats. Treatment with 3-AP alone induced plastic alterations in the cells' intrinsic properties, so that the latency of the initial neural spike was significantly increased (Pb 0.001); however, both instantaneous firing frequency and amplitude of calcium spikes were significantly (Pb 0.001) suppressed. 3-AP treatment also resulted in significant decrease in the duration of action potential (Pb 0.05) and the amplitude of afterhyperpolarization ((Pb 0.05) as well as post-stimulus hyperpolarization potentials (Pb 0.001). Purkinje cells in rats co-treated with 4-AP, however, fired predominantly in rhythmic bursts. The mean amplitude of Ca2+ spikes was significantly (Pb 0.001) greater compared to ataxic rats, but similar to control value. As evidenced by a significant decrease (Pb 0.001) in the first spike latency, the cells' intrinsic excitability was also increased. In 4-AP co-treated group, the duration of action potential was also significantly lengthened (Pb 0.001) compared to control and 3-AP group. These results suggest that modulation of intrinsic electrical properties and potentiation of Ca2+ channels function caused by in vivo 4-AP treatment is likely to be partly responsible for its neuroprotective action.Copyright (c) 2010 Elsevier B.V. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
3-Acetylpyridine
CAS:350-03-8 |
C7H7NO |
Ionic matrices pre-spotted matrix-assisted laser desorption/...
2013-03-01 [Anal. Biochem. 434(1) , 187-98, (2013)] |
Cyanoacetic acid hydrazones of 3-(and 4-)acetylpyridine and ...
2006-01-01 [Arch. Pharm. (Weinheim) 339(1) , 14-23, (2006)] |
Definitive endoderm differentiation of human-induced pluripo...
2014-11-01 [J. Biomed. Mater. Res. A 102(11) , 4027-36, (2014)] |
Attenuation of activity-induced increases in cerebellar bloo...
2003-09-01 [Am. J. Physiol. Heart Circ. Physiol. 285(3) , H1177-82, (2003)] |
[Effect of nicotinamide adenine dinucleotide on the serotoni...
2002-01-01 [Vopr. Med. Khim. 48(3) , 264-70, (2002)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved